Keita Nakane

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 23

Top Topics

Combination Therapy

Radical Prostatectomy

Prognostic Factors

Ejection Fraction

Top Venues

Current oncology (Toronto, Ont.)

Translational cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Keita Nakane, Makoto Kawase, Daiki Kato, Koji Iinuma, Kota Kawase, Shinichi Takeuchi, Yuki Tobisawa, Takayasu Ito, Takuya Koie
Combination approach using neoadjuvant therapy with radical prostatectomy for improving oncological outcomes of high-risk prostate cancer: a narrative review. Translational cancer research 13 (7) (2024)
Keita Nakane, Kazuki Taniguchi, Minori Nezasa, Torai Enomoto, Toyohiro Yamada, Risa Tomioka-Inagawa, Kojiro Niwa, Masayuki Tomioka, Takashi Ishida, Shingo Nagai, Shigeaki Yokoi, Tomoki Taniguchi, Makoto Kawase, Kota Kawase, Koji Iinuma, Yuki Tobisawa, Takuya Koie
Oncologic Outcomes of Patients with Immune Checkpoint Inhibitor Resistant Urothelial Carcinoma Treated with Enfortumab Vedotin and the Impact of Neutrophil-to-Lymphocyte Ratio and Dysgeusia on Overall Survival: A Retrospective Multicenter Cohort Study in Japan. Cancers 16 (15) (2024)
Kota Kawase, Tadanobu Chuyo Kamijo, Naohisa Kusakabe, Keita Nakane, Takuya Koie, Minoru Miyazato
Effects of low-intensity extracorporeal shock wave on bladder and urethral dysfunction in spinal cord injured rats. International urology and nephrology (2024)
Keita Nakane, Kazuki Taniguchi, Minori Nezasa, Torai Enomoto, Toyohiro Yamada, Risa Tomioka-Inagawa, Kojiro Niwa, Masayuki Tomioka, Takashi Ishida, Shingo Nagai, Shigeaki Yokoi, Tomoki Taniguchi, Makoto Kawase, Kota Kawase, Koji Iinuma, Yuki Tobisawa, Takuya Koie
Oncologic Outcomes of Patients with Immune Checkpoint Inhibitor Resistant Urothelial Carcinoma Treated with Enfortumab Vedotin and the Impact of Neutrophil-to-Lymphocyte Ratio and Dysgeusia on Overall Survival: A Retrospective Multicenter Cohort Study in Japan. Cancers 16 (15) (2024)
Keita Nakane, Makoto Kawase, Daiki Kato, Koji Iinuma, Kota Kawase, Shinichi Takeuchi, Yuki Tobisawa, Takayasu Ito, Takuya Koie
Combination approach using neoadjuvant therapy with radical prostatectomy for improving oncological outcomes of high-risk prostate cancer: a narrative review. Translational cancer research 13 (7) (2024)
Fumiya Sugino, Keita Nakane, Makoto Kawase, Shota Ueda, Masayuki Tomioka, Yasumichi Takeuchi, Risa Tomioka-Inagawa, Toyohiro Yamada, Sanae Namiki, Naotaka Kumada, Shinichi Takeuchi, Kota Kawase, Daiki Kato, Manabu Takai, Koji Iinuma, Yuki Tobisawa, Takuya Koie
Efficacy and Safety of Neoadjuvant Luteinizing Hormone-Releasing Hormone Antagonist and Tegafur-Uracil Chemohormonal Therapy for High-Risk Prostate Cancer. Life (Basel, Switzerland) 13 (5) (2023)
Shinichi Takeuchi, Koji Iinuma, Keita Nakane, Masahiro Nakano, Makoto Kawase, Kota Kawase, Manabu Takai, Daiki Kato, Takayuki Mori, Hirota Takano, Tomoyasu Kumano, Masayuki Matsuo, Takuya Koie
Direct Comparison of Two Different Definitions with Biochemical Recurrence after Low-Dose-Rate Brachytherapy for Prostate Cancer. Current oncology (Toronto, Ont.) 30 (3) (2023)
Keita Nakane, Hiromitsu Watanabe, Taku Naiki, Kiyoshi Takahara, Takahiro Yasui, Hideaki Miyake, Ryoichi Shiroki, Takuya Koie
Trends in the Use of Second-Generation Androgen Receptor Axis Inhibitors for Metastatic Hormone-Sensitive Prostate Cancer and Clinical Factors Predicting Biological Recurrence. Diagnostics (Basel, Switzerland) 13 (9) (2023)
Shinichi Takeuchi, Koji Iinuma, Keita Nakane, Masahiro Nakano, Makoto Kawase, Kota Kawase, Manabu Takai, Daiki Kato, Takayuki Mori, Hirota Takano, Tomoyasu Kumano, Masayuki Matsuo, Takuya Koie
Direct Comparison of Two Different Definitions with Biochemical Recurrence after Low-Dose-Rate Brachytherapy for Prostate Cancer. Current oncology (Toronto, Ont.) 30 (3) (2023)
Shinichi Takeuchi, Koji Iinuma, Keita Nakane, Masahiro Nakano, Makoto Kawase, Kota Kawase, Manabu Takai, Daiki Kato, Takayuki Mori, Hirota Takano, Tomoyasu Kumano, Masayuki Matsuo, Takuya Koie
Direct Comparison of Two Different Definitions with Biochemical Recurrence after Low-Dose-Rate Brachytherapy for Prostate Cancer. Current oncology (Toronto, Ont.) 30 (3) (2023)
Keita Nakane, Hiromitsu Watanabe, Taku Naiki, Kiyoshi Takahara, Takahiro Yasui, Hideaki Miyake, Ryoichi Shiroki, Takuya Koie
Trends in the Use of Second-Generation Androgen Receptor Axis Inhibitors for Metastatic Hormone-Sensitive Prostate Cancer and Clinical Factors Predicting Biological Recurrence. Diagnostics (Basel, Switzerland) 13 (9) (2023)
Yoshifumi Kadono, Hiroyuki Konaka, Takahiro Nohara, Kouji Izumi, Satoshi Anai, Kiyohide Fujimoto, Tomoyuki Koguchi, Kei Ishibashi, Noriyasu Kawai, Keita Nakane, Akinori Iba, Naoya Masumori, Shizuko Takahara, Atsushi Mizokami
Efficacy and Safety of First-Line Cytokines versus Sunitinib and Second-Line Axitinib for Patients with Metastatic Renal Cell Carcinoma (ESCAPE Study): A Phase III, Randomized, Sequential Open-Label Study. Cancers 15 (10) (2023)
Koji Iinuma, Toyohiro Yamada, Koji Kameyama, Tomoki Taniguchi, Kei Kawada, Takashi Ishida, Shingo Nagai, Torai Enomoto, Shota Ueda, Kimiaki Takagi, Makoto Kawase, Shinichi Takeuchi, Kota Kawase, Daiki Kato, Manabu Takai, Keita Nakane, Takuya Koie
The Efficacy and Safety of Immune Checkpoint Inhibitor and Tyrosine Kinase Inhibitor Combination Therapy for Advanced or Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Real-World Cohort Study. Cancers 15 (3) (2023)
Koji Iinuma, Toyohiro Yamada, Koji Kameyama, Tomoki Taniguchi, Kei Kawada, Takashi Ishida, Shingo Nagai, Torai Enomoto, Shota Ueda, Kimiaki Takagi, Makoto Kawase, Shinichi Takeuchi, Kota Kawase, Daiki Kato, Manabu Takai, Keita Nakane, Takuya Koie
The Efficacy and Safety of Immune Checkpoint Inhibitor and Tyrosine Kinase Inhibitor Combination Therapy for Advanced or Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Real-World Cohort Study. Cancers 15 (3) (2023)
Keita Nakane, Toyohiro Yamada, Risa Tomioka-Inagawa, Fumiya Sugino, Naotaka Kumada, Makoto Kawase, Shinichi Takeuchi, Kota Kawase, Daiki Kato, Manabu Takai, Koji Iinuma, Takuya Koie
Efficacy and Safety of the "Trisection Method" Training System for Robot-Assisted Radical Cystectomy at a Single Institution in Japan. Current oncology (Toronto, Ont.) 29 (12) (2022)
Koji Iinuma, Risa Tomioka-Inagawa, Koji Kameyama, Tomoki Taniguchi, Kei Kawada, Takashi Ishida, Shingo Nagai, Torai Enomoto, Shota Ueda, Makoto Kawase, Shinichi Takeuchi, Kota Kawase, Daiki Kato, Manabu Takai, Keita Nakane, Takuya Koie
Efficacy and Safety of Cabozantinib in Patients with Advanced or Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Cohort Study. Biomedicines 10 (12) (2022)
Keita Nakane, Toyohiro Yamada, Risa Tomioka-Inagawa, Fumiya Sugino, Naotaka Kumada, Makoto Kawase, Shinichi Takeuchi, Kota Kawase, Daiki Kato, Manabu Takai, Koji Iinuma, Takuya Koie
Efficacy and Safety of the "Trisection Method" Training System for Robot-Assisted Radical Cystectomy at a Single Institution in Japan. Current oncology (Toronto, Ont.) 29 (12) (2022)
Koji Iinuma, Risa Tomioka-Inagawa, Koji Kameyama, Tomoki Taniguchi, Kei Kawada, Takashi Ishida, Shingo Nagai, Torai Enomoto, Shota Ueda, Makoto Kawase, Shinichi Takeuchi, Kota Kawase, Daiki Kato, Manabu Takai, Keita Nakane, Takuya Koie
Efficacy and Safety of Cabozantinib in Patients with Advanced or Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Cohort Study. Biomedicines 10 (12) (2022)
Keita Nakane, Toyohiro Yamada, Risa Tomioka-Inagawa, Fumiya Sugino, Naotaka Kumada, Makoto Kawase, Shinichi Takeuchi, Kota Kawase, Daiki Kato, Manabu Takai, Koji Iinuma, Takuya Koie
Efficacy and Safety of the "Trisection Method" Training System for Robot-Assisted Radical Cystectomy at a Single Institution in Japan. Current oncology (Toronto, Ont.) 29 (12) (2022)
Keita Nakane, Toyohiro Yamada, Risa Tomioka-Inagawa, Fumiya Sugino, Naotaka Kumada, Makoto Kawase, Shinichi Takeuchi, Kota Kawase, Daiki Kato, Manabu Takai, Koji Iinuma, Takuya Koie
Efficacy and Safety of the "Trisection Method" Training System for Robot-Assisted Radical Cystectomy at a Single Institution in Japan. Current oncology (Toronto, Ont.) 29 (12) (2022)
Keita Nakane, Toyohiro Yamada, Risa Tomioka-Inagawa, Fumiya Sugino, Naotaka Kumada, Makoto Kawase, Shinichi Takeuchi, Kota Kawase, Daiki Kato, Manabu Takai, Koji Iinuma, Takuya Koie
Efficacy and Safety of the "Trisection Method" Training System for Robot-Assisted Radical Cystectomy at a Single Institution in Japan. Current oncology (Toronto, Ont.) 29 (12) (2022)
Makoto Kawase, Keita Nakane, Sanae Namiki, Yasumichi Takeuchi, Shota Ueda, Kota Kawase, Chie Nakai, Shinichi Takeuchi, Daiki Kato, Manabu Takai, Koji Iinuma, Masayuki Fuwa, Chiemi Saigo, Tatsuhiko Miyazaki, Hiroyuki Morita, Takuya Koie
A Case of Localized Prostate Cancer Associated with Polymyalgia Rheumatica with Marked Symptomatic Improvement after Robot-Assisted Radical Prostatectomy. Case reports in urology 2021 (2021)
Yasumichi Takeuchi, Daiki Kato, Keita Nakane, Kota Kawase, Manabu Takai, Koji Iinuma, Chiemi Saigo, Tatsuhiko Miyazaki, Takuya Koie
Solitary Fibrous Tumor of the Prostate: A Case Report and Literature Review. Medicina (Kaunas, Lithuania) 57 (11) (2021)